Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07446114 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Functional Outcomes and Control Using Synchron BCI - Canada

Study acronym: FOCUS-CAN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Start date changed from estimate of Mar 2026 to Mar 18, 2026v4
  3. Recruitment opened Site details revised at 2 of 2 sitesv3 Show 1 more changeShow less
    • Site details revised at 2 of 2 sites
  4. Study sites: 1 to 2 Completion date: Jun 2027 to Jul 2027 · Start date: Feb 2026 to Mar 2026 · Eligibility criteria shortened, about 42 words · 2 morev2 Show 5 more changesShow less
    • Completion date: Jun 2027 to Jul 2027
    • Start date: Feb 2026 to Mar 2026
    • Eligibility criteria shortened, about 42 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Study title shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Synchron, Inc.
3 trials monitored
See all monitored trials
ALS
387 trials monitored
See 18 trials at risk
Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN)
Trial Details
NCT Number NCT07446114
Lead Sponsor Synchron, Inc.
Conditions Neurologic Disorder, ALS, Motor Neuron Disease
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov